摘要:
The present invention relates to polypeptides characterized by containing an amino acid sequence that is the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, or amides, esters or salts thereof, which are useful for developing pharmaceuticals such as GH secretion controlling agents; DNAs encoding these polypeptides, or amides, esters or salts thereof; a method/kit for screening a compound capable of changing the binding properties of these polypeptides to GHSR; etc.
摘要翻译:本发明涉及多肽,其特征在于含有与SEQ ID NO:1所示的氨基酸序列相同或基本相同的氨基酸序列或其酰胺,酯或盐,其可用于开发药物如 GH分泌控制剂; 编码这些多肽的DNA或其酰胺,酯或其盐; 用于筛选能够将这些多肽的结合特性改变为GHSR的化合物的方法/试剂盒; 等等
摘要:
The present invention relates to a novel polypeptide, its partial peptide or salt thereof, a method for manufacturing the polypeptide, a receptor of the polypeptide, a pharmaceutical composition comprising the polypeptide or the like, an antibody to the polypeptide, a method/kit for screening a compound that promotes or inhibits an activity of the polypeptide or salt thereof, a compound that can be obtained by the screening, a pharmaceutical composition comprising the compound, and the like. The polypeptide, its partial peptide or the like of the present invention can be used, for example, as a therapeutic agent for nervous disease, a promoting agent for somatostatin secretion and the like. Further, the antibody of the present invention can be used for a quantification of the polypeptide of the present invention in a sample solution. Furthermore, the polypeptide of the present invention is useful for a reagent for screening a compound that promotes or inhibits the activity of the polypeptide of the present invention.
摘要:
By using (1) a G protein-coupled receptor protein having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1 or its salt and (2) a fatty acid or an eicosanoid, a compound or its salt that can change the binding properties of the receptor protein or its salt to the fatty acid or the eicosanoid can be screened efficiently.
摘要翻译:通过使用(1)具有与SEQ ID NO:1所示的氨基酸序列相同或基本相同的氨基酸序列的G蛋白偶联受体蛋白或其盐和(2)脂肪酸或类花生酸,化合物 或者可以有效地筛选能够将受体蛋白质或其盐与脂肪酸或类花生酸形成的结合性质改变的盐。
摘要:
The present invention relates to the murine-derived ligand polypeptide for the G protein-coupled receptor proteins. The ligand polypeptide or the DNA which codes for the ligand polypeptide can be used for (1) development of medicines such as pituitary function modulators, central nervous system function modulators, and pancreatic function modulators, (2) development of receptor binding assay systems using the expression of recombinant receptor proteins and screening of pharmaceutical candidate compounds, and (3) production of non-human transgenic animals or non-human knockout animals for analyzing a function of the genes.
摘要:
Secretory proteins comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by, for example, SEQ ID NO: 23 are useful physiologically active substances binding to AQ27 receptor.
摘要翻译:包含与例如SEQ ID NO:23表示的氨基酸序列相同或基本相同的氨基酸序列的分泌蛋白质是与AQ27受体结合的有用的生理活性物质。
摘要:
The peptides and precursors thereof, inclusive salts thereof, of the present invention are useful as a pharmaceutical composition, for example as therapeutic or prophylactic agents for hormone-producing tumors, acromegaly, gigantism, dementia, gastric ulcer and the like, hormone secretion inhibitors, tumor growth inhibitors, neural activity or sleep modulators, etc. The DNAs coding for the peptides or precursors of the invention are useful as a pharmaceutical composition, for example as agents for the gene therapy or prevention of hormone-producing tumors, acromegaly, gigantism, dementia, gastric ulcer and the like, hormone secretion inhibitors, tumor growth inhibitors, neural activity or sleep modulators, etc. Furthermore, the DNAs coding for the peptides or precursors of the invention are useful as agents for the gene diagnosis of various diseases, for example, hormone-producing tumors, acromegaly, gigantism, dementia, gastric ulcer, etc. The antibodies against the peptides, precursors or salts of the invention can be used for assaying the peptides, precursors or salts of the invention in test solutions. The peptides, precursors or salts of the invention are useful as reagents for screening for compounds, or salts thereof, capable of modifying the binding of the peptides, precursors or sets of the invention to certain receptors.
摘要:
The present invention relates to the ligand polypeptide for the human pituitary- and mouse pancreas-derived G protein-coupled receptor proteins. The ligand polypeptide or the DNA which codes for the ligand polypeptide can be used for (1) development of medicines such as pituitary function modulators, central nervous system function modulators, and pancreatic function modulators, and (2) development of receptor binding assay systems using the expression of recombinant receptor proteins and screening of pharmaceutical candidate compounds. In particular, by the receptor binding assay systems utilizing the expression of recombinant G protein-coupled receptor proteins in accordance with the invention, agonists and antagonists of G protein-coupled receptors which are specific to human and other warm-blooded animals can be screened and the agonists or antagonists obtained can be used as therapeutic and prophylactic agents for various diseases.
摘要:
A GPR7 ligand containing the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO:1 wherein the N-terminal amino acid residue may optionally be brominated, is useful in developing a receptor-binding assay system with the use of the GPR7 expression system, in screening a candidate compound for a drug such as an antiobestic, etc.
摘要:
A method of screening a compound or a salt thereof that alters the binding property of Neuromedin U with FM-3, characterized by using Neuromedin U, a derivative thereof or a salt thereof and FM-3 or a salt thereof of the present invention, can be used for screening a therapeutic and/or prophylactic agent for hypertension or stress-related diseases. A FM-3 antagonist is useful as a therapeutic and/or prophylactic agent for hypertension or stress-related diseases.
摘要:
The present invention relates to a human-derived G-protein coupled receptor protein or a partial peptide thereof or a salt thereof, a nucleic acid encoding said receptor protein and a derivative thereof. A G-protein coupled receptor protein derived from a human hippocampus according to the invention or a nucleic acid encoding said protein and a derivative thereof can be used in determining a ligand (agonist) for a G-protein coupled receptor protein of the invention, in a preventing and/or treating agent against a disease related to a dysfunction of a G-protein coupled receptor protein of the invention, in a gene diagnostic agent, and in screening for a compound capable of altering the expression level of a receptor protein of the invention or a partial peptide thereof.